Matches in Nanopublications for { ?s ?p "[We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP828402.RAg_S6kAwCRbcrIpVjJu_lB3cNi4SHcbnt4Ox-sKOxvL0130_assertion description "[We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828402.RAg_S6kAwCRbcrIpVjJu_lB3cNi4SHcbnt4Ox-sKOxvL0130_provenance.
- NP828387.RAIbF3Fpc3j6xkos2E63fP9OznR_PB6g-IG9J1xJtlJR4130_assertion description "[We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828387.RAIbF3Fpc3j6xkos2E63fP9OznR_PB6g-IG9J1xJtlJR4130_provenance.
- NP1141487.RAph5pKRldLeuL7g5XF3Em0YwLhRiVZbVXt34EHTIHrOc130_assertion description "[We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141487.RAph5pKRldLeuL7g5XF3Em0YwLhRiVZbVXt34EHTIHrOc130_provenance.